On April 21st, 2026, RxE2 hosted a landmark virtual fireside chat between CEO Gerald Finken and Craig Lipset, Co-Founder of the Decentralized Trials & Research Alliance (DTRA). The conversation moved beyond the buzzwords of virtual trials to address the fundamental architecture of how we develop medicines. The Crisis of Access: Three Inputs, One Major Bottleneck…
The clinical trial landscape is changing. Are you ready for what’s next? Decentralized Clinical Trials (DCTs) have evolved rapidly since their initial inception over a decade ago. While the COVID-19 pandemic accelerated their adoption, the industry is now at a crossroads. As we move beyond the initial hype, the focus has shifted toward sustainability, cost-effectiveness,…
Introduction Following our deep dive into the mechanics of clinical trials with Austin Tull, we continue our series aimed at demystifying the evolving landscape of clinical research. While the “what” of clinical trials is rooted in safety and efficacy, the “how” is undergoing a radical transformation. This shift is known as Decentralized Clinical Trials (DCT),…
Introduction Clinical trials are the backbone of modern medicine, serving as the essential gateway through which new treatments must pass to ensure they are safe and effective for widespread public use. Yet, the process often seems mysterious, complex, and highly institutionalized. We sat down with Austin Tull, a licensed pharmacist with extensive experience overseeing large…
We are delighted to share the insights and collaborative energy from the first of its kind un-conference for Pharmacists in clinical research, hosted by RxE2. Held on October 24th, 1 pm ET, this landmark event occurred during American Pharmacists Month, emphasizing the profession’s pivotal role in advancing healthcare. For those who missed the dynamic conversations,…
Introduction In the highly regulated ecosystem of clinical research, innovation often feels slow, confined by complex protocols and centralized infrastructures. Yet, a quiet revolution is taking place, driven by technology that is fundamentally shifting where and how clinical trials are conducted. At the forefront of this movement is RxE2, and guiding the technological architecture that…
Pharmacists hold a unique and powerful position in healthcare, not only as medication experts but also as some of the most trusted professionals that patients encounter regularly. Trust is an essential element in healthcare because it influences how patients follow treatments, share information, and engage in health programs such as clinical trials. While doctors and…
Introduction As American Pharmacists Month draws to a close, RxE2 recognizes the vital and evolving role pharmacists play in healthcare and clinical advancement. To cap off our campaign, we sat down with Teresa Gerbig, PharmD, Pharmacy Network Manager at RxE2, to discuss her personal journey, the unique position of pharmacists in clinical research, and how…
Introduction Continuing with our American Pharmacists Month features, we are especially excited to celebrate Women Pharmacists Day on October 12th by highlighting the incredible expertise and dedication of the Woman Pharmacists of RxE2. Today, we sat down with Shavon Singh, PharmD, Director of Pharmacy Services at RxE2, to discuss her diverse career journey, the evolving…
Join fellow pharmacists for the first ever un-conference, by pharmacists, for pharmacists! Save the date!!! Join us for the first ever pharmacists “un-conference” – a participant led event. We invite all pharmacists who are already involved in, or are interested in clinical trials to join the discussion. You can still suggest discussion topics for 15…